Stenocare Concludes CannGros Integration, Corporate Merger
Stenocare (STENO.CO) wrapped up the operational integration, process optimization, and corporate merger of CannGros by the end of June, according to a July 3 release. Acquired in November 2025, CannGros is anticipated to boost Stenocare's product portfolio and position in the Danish medical cannabis market. Stenocare also expects the optimization of the repackaging process to improve both cost and lead time.
Stenocare (STENO.CO) wrapped up the operational integration, process optimization, and corporate merger of CannGros by the end of June, according to a July 3 release.
Acquired in November 2025, CannGros is anticipated to boost Stenocare's product portfolio and position in the Danish medical cannabis market.
Stenocare also expects the optimization of the repackaging process to improve both cost and lead time.